Literature DB >> 8034995

Fusobacterial infections in children.

I Brook1.   

Abstract

A total of 243 strains of Fusobacteria species was recovered from 226 of 1399 (16%) specimens obtained from 213 children. The strains included 65 (27%) Fusobacterium sp., 144 (59%) Fusobacterium nucleatum, 25 (10%) Fusobacterium necrophorum, five (2%) Fusobacterium varium, three (1%) Fusobacterium mortiferum, and one (0.4%) Fusobacterium gonidiaformans. Most Fusobacteria species were recovered from patients with abscesses (100), aspiration pneumonia (24), paronychia (15), bites (14), chronic sinusitis (ten), chronic otitis media (nine), and osteomyelitis (eight). Predisposing conditions were noted in 32 (15%) of the cases. These included immunodeficiency in nine (4%), steroid therapy in eight (4%), previous surgery in six (3%), diabetes in six (3%) and malignant neoplasms in five (2%). Fusobacteria sp. was the only isolate in 16 (8%) instances while mixed infections were encountered in 197 (92%) patients. The organisms most commonly isolated with Fusobacteria sp. were anaerobic cocci (155), pigmented Prevotella sp. and Porphyromonas sp. (95), Bacteroides fragilis group (80), Escherichia coli (43) and Bacteroides sp. (39). Most strains of B. fragilis group and E. coli were recovered from intra-abdominal infections and skin and soft tissue infections proximal to the rectal area. Most pigmented Prevotella sp. and Porphyromonas sp. were recovered from oropharyngeal and pulmonary sites and from sites around the head and neck. Antimicrobial therapy was administered to all patients; surgical drainage was performed in 85 (40%). All patients, except two who died, recovered. These findings illustrate the prevalence of Fusobacteria sp. associated with infections in children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034995     DOI: 10.1016/s0163-4453(94)95600-6

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  19 in total

1.  beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.

Authors:  E Könönen; A Kanervo; K Salminen; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Pyogenic liver abscess caused by Fusobacterium in a 21-year-old immunocompetent male.

Authors:  Zohair Ahmed; Saurabh K Bansal; Sonu Dhillon
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

3.  Thyroid abscess due to a mixed anaerobic infection with Fusobacterium mortiferum.

Authors:  Nikolaos P Stavreas; Constantina D Amanatidou; Emmanuel G Hatzimanolis; Ioannis Legakis; George Naoum; Elli Lakka-Papadodima; George Georgoulias; Panagiota Morfou; Sotirios Tsiodras
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

5.  Lemierre syndrome : Three cases of "the forgotten" disease.

Authors:  Jytte Banner Lundemose; Poul Frederiksen; Ingrid Bayer Kristensen
Journal:  Forensic Sci Med Pathol       Date:  2005-12       Impact factor: 2.007

6. 

Authors:  Karen Arane; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

7.  Fusobacterium infections in children.

Authors:  Karen Arane; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

8.  Fusobacterial infections in children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

9.  Anaerobic septicaemia by Fusobacterium necrophorum: Lemierre's syndrome.

Authors:  B Dhawan; R Chaudhry; A Pandey; N Nisar; M Singh
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

10.  Fusobacterium invasive infections in children: a retrospective study in two French tertiary care centres.

Authors:  M Bailhache; P Mariani-Kurkdjian; P Lehours; J Sarlangue; P Pillet; E Bingen; A Faye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.